19th Meeting of the
EAU Section of Oncological Urology
Access the Resource Centre

Static homepage

Dear friends and colleagues,

From the emergence of COVID-19 in 2020 to adapting to the pandemic’s impact in the present, we as healthcare providers need to forge on as our cancer patients need our support in these trying times. In addition, individual therapy and personalised medicine in oncology have leaped swiftly from theory to practice. The treatment of cancer is no longer a fight against a disease in an organ but against cancerous cells that can spread out from the organ. Urologists will further focus on the treatment of the cancerous cells in lieu of surgical extirpation of the organ.

To equip you with relevant contemporary updates on genitourinary cancers, expect no less than outstanding knowledge exchange at the 19th Meeting of the EAU Section of Oncological Urology (ESOU22). Regardless of the COVID-19 outbreak, the meeting’s scientific programme continues to evolve as it does year after year. It is perpetually designed to bolster your clinical practice and patient care, fortifying the ESOU meeting’s standing as an essential, reputable European reference.

Access the Resource Centre

Prof. Morgan Rouprêt ESOU Chairman

Prof. Morgan Rouprêt
Chairman EAU Section of Oncological Urology

Why you should attend this meeting

Outstanding programme

The highly-interactive meeting is blend of round-table discussions, scientific lectures, and rapid-fire presentations.

Essential GU updates

ESOU22 will provide you with the newest and relevant developments on GU treatments and strategies.

Vital knowledge exchange

Especially in the time of the pandemic, it is imperative to continue to provide our cancer patients with optimal care.

Latest news